MLYS Mineralys Therapeutics, Inc.
$28.20▼ -3.75%
Healthcare
Other
After hours
$28.20▲ +0.00%
Sep 11, 7:30 PM ET
Volume 1.73M
Avg Volume (10D) 1.25M
Key Metrics & Fundamentals
Market Cap
$2.49B
P/E Ratio
–
Div Yield
–%
52W Range
22.30 - 47.65
% vs 50 MA
3.56%
% vs 200 MA
-3.94%
RSI-14
53.5
MACD Histogram
+0.3400
Beta (1Y vs SPY)
1.14
Free Cash Flow
-$32.56M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$246.04M
COGS
–
Operating Exp
$246.04M
Operating Income
-$246.04M
EBIT
-$246.04M
Pretax Income
-$241.07M
Net Income
-$241.07M
EPS (Diluted)
-2.85
Price & Volume History
Loading chart…
Recent News
Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · Sep 9, 2026 8:05 PM
Mineralys Therapeutics to Participate in the Wells Fargo 21st Annual Healthcare Conference
GlobeNewswire · Aug 26, 2026 12:00 PM
Mineralys (MLYS) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 18, 2026 11:13 PM
Mineralys Therapeutics Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · Aug 13, 2026 8:05 PM
Mineralys Therapeutics Inc (MLYS) (Q2 2026) Earnings Call Highlights: Strong Cash Position and ...
GuruFocus.com · Aug 12, 2026 5:01 AM
Mineralys Therapeutics, Inc. Q2 2026 Earnings Call Summary
Moby · Aug 12, 2026 2:49 AM
Mineralys Therapeutics Q2 Earnings Call Highlights
MarketBeat · Aug 11, 2026 11:04 PM
Mineralys Therapeutics Q2 Loss Widens
MT Newswires · Aug 11, 2026 8:46 PM
Mineralys Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
GlobeNewswire · Aug 11, 2026 8:05 PM
Mineralys Therapeutics (MLYS) Heads Into Earnings As Lorundrostat Hopes Meet Undervalued View
Simply Wall St. · Aug 5, 2026 11:10 AM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See MLYS's money flow as a full page
Social Sentiment
Avg -0.07 · 3 posts
DDTradeWhere the Big Money Just Went All In - DD
r/wallstreetbets · Feb 9, 2026
Fade the rip energy suggests a bearish outlook.
negative
-0.40
list of all pre-revenue companies sorted by market capitalization.
r/stocks · Sep 24, 2025
The post highlights speculative stocks with zero revenue and criticizes valuations, suggesting caution towards MLYS.
negative
-0.60
DDTradePriceTargetMLYS Huhe Upward Move!
r/wallstreetbets · Sep 3, 2025
The author expresses excitement and encourages further research, indicating a bullish sentiment.
very_positive
+0.80
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.